Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
02/2002
02/28/2002WO2002016647A1 Methods and compositions for identifying nucleic acid molecules using nucleolytic activities and hybridization
02/28/2002WO2002016384A2 Apparatus and methods for the automated synthesis of oligosaccharides
02/28/2002WO2002016381A2 Composition and method for inhibiting platelet aggregation
02/28/2002WO2002016375A1 Novel amidite derivatives for synthesising polymers on surfaces
02/28/2002WO2002016023A2 Method and apparatus for in situ synthesis on a solid support
02/28/2002WO2002016022A2 Novel strategie for synthesising polymers on surfaces
02/28/2002WO2001071732B1 Porous ferro- or ferrimagnetic glass particles for isolating molecules
02/28/2002US20020026046 Mixing composition with reducing agent, heating; wherein any ribonucleases in composition are substantially inactivated or inhibited
02/28/2002US20020026044 For treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, psoriasis; for wound healing
02/28/2002US20020025572 Separating nucleotide sequences in sample; obtain sample, extract nucleotide sequences, incubate sample with nucleotide sequence carrier, separate bound nucleotide sequences, dissociate nucleotide sequences, recover nucleotide sequences
02/28/2002US20020025528 Use of genetic markers to diagnose familial dysautonomia
02/28/2002US20020025305 Cell-cycle regulatory proteins, and uses related thereto
02/28/2002CA2420179A1 Composition and method for inhibiting platelet aggregation
02/28/2002CA2418127A1 Transgenic plants with enhanced phenotypic properties and methods for producing them
02/28/2002CA2386913A1 Methods for external controls for nucleic acid amplification
02/27/2002EP1182206A2 Stabilized oligonucleotids and the use thereof
02/27/2002EP1181390A1 27 human secreted proteins
02/27/2002EP1181335A1 Extended rhodamine compounds useful as fluorescent labels
02/27/2002EP1181304A1 Antiproliferative activity of g-righ oligonucleotides and method of using same to bind to nucleolin
02/27/2002EP1181301A1 Oligonucleotide synthesis with lewis acids as activators
02/27/2002EP1130117A9 Method and device for detection of nucleic acid using total internal reflectance
02/27/2002EP1130116A9 Method and device for detection of nucleic acid using total internal reflectance
02/27/2002EP1100809A4 Rna targeted 2'-modified oligonucleotides that are conformationally preorganized
02/27/2002EP0536330B1 Glyphosate tolerant plants
02/27/2002CN1079832C Polypeptide for expressing virus of pig reproduction and respiration syndrome in same cell
02/27/2002CN1079830C Methods and materials for treatment of individuals infected with intracellular infections agents
02/26/2002US6350863 3, 4-di(acylamino)phenyl ribofuranosides, 2'-deoxyribofuranosides, and methods of making
02/26/2002US6350853 Conjugated peptide nucleic acids having enhanced cellular uptake
02/26/2002US6350595 Utilizing alternating presynthesized mononucleotide and presynthesized dinucleotide as monomeric synthesis unit, carrying out synthesis on support
02/26/2002US6350592 Aortic-specific enhancer sequence and uses thereof
02/26/2002CA2072484C Use of nadh or nadph against cancer and aids
02/21/2002WO2002014867A2 Ultra-sensitive detection systems
02/21/2002WO2002014558A2 New hydrazide building blocks and hydrazide modified biomolecules
02/21/2002WO2002014555A2 Single-labeled oligonucleotide probes
02/21/2002WO2002014545A2 Method for determining weather a test compound binds to a large rna target
02/21/2002WO2002014340A1 Processes for the preparation of oligonucleotides_______________
02/21/2002WO2001081608A3 Viral vectors for use in monitoring hiv drug resistance
02/21/2002WO2001060856A3 Vmglom gene and its mutations causing disorders with a vascular component
02/21/2002WO2001057264A3 Electron-deficient nitrogen heterocycle-substituted fluorescein dyes
02/21/2002WO2001018524A3 Methods for improving signal detection from an array
02/21/2002US20020022721 Methods of array synthesis
02/21/2002US20020022033 Diagnosis of Aids
02/21/2002US20020022001 Nucleosides for imaging and treatment applications
02/21/2002CA2419159A1 Ultra-sensitive detection systems
02/21/2002CA2417986A1 Single-labeled oligonucleotide probes
02/20/2002EP1180113A1 Oligonucleotides having a-dna form and b-dna form conformational geometry
02/20/2002EP1180112A1 Detection using degradation of a tagged sequence
02/20/2002EP1180111A1 Method and apparatus for compound library preparation using optical modulator
02/20/2002EP0749485B1 Antimicrobial proteins from impatiens
02/19/2002US6348596 Non-fluorescent asymmetric cyanine dye compounds useful for quenching reporter dyes
02/19/2002US6348589 Certain dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency
02/19/2002US6348588 Method of cleaving a nucleic acid bulge
02/19/2002US6348583 Nucleobase containing polythioethers synthesized on polyethylene glycol, succinic anhydride and propylamine modified glass; nucleic acid mimetics
02/19/2002US6348312 Oligonucleotide having length of 6-100 nucleotides, wherein at least one non-terminal pyrimidine nucleoside is modified, and also 5' and/or 3' ends are modified, by replacement of 3' and/or 5' phosphodiester bridge by phosphorothioate bridge
02/19/2002CA2141060C Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods
02/14/2002WO2002012902A2 Split-ubiquitin based reporter systems and methods of their use
02/14/2002WO2002012567A1 Vhl promoter diagnostic polymorphism
02/14/2002WO2002012566A2 The use and evaluation of a [2+2] photocycloaddition in immobilization of oligonucleotides on a three-dimensional hydrogel matrix
02/14/2002WO2002012565A1 Association of sim2 with cancer
02/14/2002WO2002012263A1 Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses
02/14/2002WO2001075139A8 Reversible chemical modification of nucleic acids and improved method for nucleic acid hybridization
02/14/2002WO2001059093A3 Full-length infectious cdna clones of tick borne flavivirus
02/14/2002WO2001036439A3 Method for constructing oligodesoxyribonucleotide binomial libraries with codon mutagenized using desoxynucleoside-phosphoramitides
02/14/2002US20020019481 Non-luminescent substrate
02/14/2002US20020019359 Oligonucleotide with a base sequence complementary to a target portion of a nucleic acid encoding angiogenin
02/14/2002DE10038237A1 Verfahren zum Nachweis von Mutationen in Nucleotidsequenzen A method for detecting mutations in nucleotide sequences
02/14/2002CA2569615A1 Nucleic acid binding compounds containing pyrazolo[3,4-d] pyrimidine analogues of purin-2,6-diamine and their uses
02/14/2002CA2453907A1 Association of sim2 with cancer
02/14/2002CA2418094A1 Vhl promoter diagnostic polymorphism
02/14/2002CA2417888A1 Split-ubiquitin based reporter systems and methods of their use
02/13/2002EP1179350A2 Encapsulated cell system for implantation into the human CNS
02/13/2002EP1179057A2 pH DEPENDENT ION EXCHANGE MATRIX AND METHOD OF USE IN THE ISOLATION OF NUCLEIC ACIDS
02/13/2002EP1179028A1 Solvent resistant photosensitive compositions
02/13/2002EP1179003A1 Methods for increasing plant cell proliferation by functionally inhibiting a plant cyclin inhibitor gene
02/13/2002EP1179000A2 Secreted proteins and uses thereof
02/13/2002EP1178999A2 L-ribo-lna analogues
02/13/2002EP1178722A1 eNOS MUTATIONS USEFUL FOR GENE THERAPY AND THERAPEUTIC SCREENING
02/13/2002EP0912470B1 Method and device for purifying and enriching molecules
02/13/2002EP0866878A4 Detection of mammary tumor virus-like sequences in human breast cancer
02/13/2002CN1335936A Coupling of lipopolysaccharide-derived carbohydrates onto solid surfaces
02/12/2002US6346655 Trichothecne-Resistant transgenic plants
02/12/2002US6346614 Hybrid oligonucleotide phosphorothioates
02/12/2002US6346613 An antisense oligonucleotide that hybridizes with a occludin mrna and disrupts tight junctions, to increase cell layer permeability to solutes and drugs
02/12/2002US6346611 High affinity TGfβ nucleic acid ligands and inhibitors
02/12/2002US6346510 Antiproliferative, anticarcinogenic and antitumor agents
02/12/2002US6346423 Methods and compositions for producing biopolymeric arrays
02/12/2002US6346416 Antisense inhibition of HPK/GCK-like kinase expression
02/12/2002US6346413 Polymer arrays
02/12/2002US6346407 Xylanase, microorganisms producing it, DNA molecules, methods for preparing this xylanase and uses of the latter
02/12/2002US6346398 Ribozyme or antisense nucleic acid which inhibits synthesis, gene expression and/or stability of messenger rna encoding the flt-1 receptor of human or mouse receptor; treatment of diabetic retinopathy; angiogenesis inhibitors
02/12/2002US6346394 Dna having specific nucleotide sequence; for recombinant production of enzyme and high yield, industrial scale production of trehalose
02/12/2002US6346387 Detection of binding reactions using labels detected by mediated catalytic electrochemistry
02/12/2002US6346378 Nucleic acid analogs with a chelating functionality
02/12/2002US6346246 Antibodies that bind human haemopoietic maturation factor
02/12/2002CA2131837C High molecular weight surface proteins of non-typeable haemophilus
02/07/2002WO2002010758A2 Surface-attached polyfunctional polymer networks for sensor chips
02/07/2002WO2002010458A2 Method of performing subtractive hybridization
02/07/2002WO2002010455A2 Methods for identifying genomic deletions
02/07/2002WO2002010449A2 Oligonucleotide library for detecting rna transcripts and splice variants that populate a transcriptome
02/07/2002WO2002010432A2 Triphosphate oligonucleotide modification reagents and uses thereof